Development and Validation of Spectrophotometric Methods for the Determination of Rasagiline in Pharmaceutical Preparations

Table 3

Analysis of RSG in tablet containing 50 mg of the drug [𝑛=5].

	Method A; [Mean ± S.D.^c]	Method B; [Mean ± S.D.^c]	Method C; [Mean ± S.D.^c]
Mean ± S.D	1.016 ± 0.0029	1.007 ± 0.046	1.013 ± 0.0027
Recovery [%]	101.60	100.65	101.32
RSD [%]	0.29	0.46	0.26

aRasalas tablet [1 mg].
^bFive independent analyses.
^cStandard deviation.